|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 33483 |
FusionGeneSummary for SFMBT1_TKT |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SFMBT1_TKT | Fusion gene ID: 33483 | Hgene | Tgene | Gene symbol | SFMBT1 | TKT | Gene ID | 51460 | 7086 |
| Gene name | Scm like with four mbt domains 1 | transketolase | |
| Synonyms | RU1|SFMBT|hSFMBT | HEL-S-48|HEL107|SDDHD|TK|TKT1 | |
| Cytomap | 3p21.1 | 3p21.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | scm-like with four MBT domains protein 1Scm-related gene containing four mbt domainsScm-related gene product containing four mbt domainsrenal ubiquitous protein 1 | transketolaseepididymis luminal protein 107epididymis secretory protein Li 48 | |
| Modification date | 20180519 | 20180519 | |
| UniProtAcc | Q9UHJ3 | P29401 | |
| Ensembl transtripts involved in fusion gene | ENST00000394752, ENST00000394750, ENST00000358080, ENST00000296295, ENST00000470575, | ENST00000462138, ENST00000423525, ENST00000461139, ENST00000423516, ENST00000296289, | |
| Fusion gene scores | * DoF score | 11 X 8 X 8=704 | 8 X 8 X 6=384 |
| # samples | 12 | 12 | |
| ** MAII score | log2(12/704*10)=-2.55254102302878 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(12/384*10)=-1.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: SFMBT1 [Title/Abstract] AND TKT [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SFMBT1 | GO:0045892 | negative regulation of transcription, DNA-templated | 23592795 |
| Tgene | TKT | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process | 9611778 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | STAD | TCGA-R5-A7ZE-01B | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3CDS | ENST00000394752 | ENST00000462138 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-3CDS | ENST00000394752 | ENST00000423525 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-intron | ENST00000394752 | ENST00000461139 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-intron | ENST00000394752 | ENST00000423516 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-5UTR | ENST00000394752 | ENST00000296289 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-3CDS | ENST00000394750 | ENST00000462138 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-3CDS | ENST00000394750 | ENST00000423525 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-intron | ENST00000394750 | ENST00000461139 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-intron | ENST00000394750 | ENST00000423516 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-5UTR | ENST00000394750 | ENST00000296289 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-3CDS | ENST00000358080 | ENST00000462138 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-3CDS | ENST00000358080 | ENST00000423525 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-intron | ENST00000358080 | ENST00000461139 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-intron | ENST00000358080 | ENST00000423516 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-5UTR | ENST00000358080 | ENST00000296289 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-3CDS | ENST00000296295 | ENST00000462138 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-3CDS | ENST00000296295 | ENST00000423525 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-intron | ENST00000296295 | ENST00000461139 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-intron | ENST00000296295 | ENST00000423516 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| 5UTR-5UTR | ENST00000296295 | ENST00000296289 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-3CDS | ENST00000470575 | ENST00000462138 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-3CDS | ENST00000470575 | ENST00000423525 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-intron | ENST00000470575 | ENST00000461139 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-intron | ENST00000470575 | ENST00000423516 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
| intron-5UTR | ENST00000470575 | ENST00000296289 | SFMBT1 | chr3 | 53079832 | - | TKT | chr3 | 53276258 | - |
Top |
FusionProtFeatures for SFMBT1_TKT |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SFMBT1 | TKT |
| Histone-binding protein, which is part of variouscorepressor complexes. Mediates the recruitment of corepressorcomplexes to target genes, followed by chromatin compaction andrepression of transcription. Plays a role during myogenesis:required for the maintenance of undifferentiated states ofmyogenic progenitor cells via interaction with MYOD1. Interactionwith MYOD1 leads to the recruitment of associated corepressors andsilencing of MYOD1 target genes. Part of the SLC complex in germcells, where it may play a role during spermatogenesis.{ECO:0000269|PubMed:17599839, ECO:0000269|PubMed:23349461,ECO:0000269|PubMed:23592795}. | Catalyzes the transfer of a two-carbon ketol group froma ketose donor to an aldose acceptor, via a covalent intermediatewith the cofactor thiamine pyrophosphate.{ECO:0000269|PubMed:27259054}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SFMBT1_TKT |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SFMBT1_TKT |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| SFMBT1 | PHC1, ACP1, PHC2, HIST1H3A, HIST1H4A, PSMA1, SRPK1, ZCCHC10, CLNK, KIF22, RBPJ, HDAC1, HMG20A | TKT | TKT, ATG5, PIK3C2A, H2AFX, HDAC5, ISG15, TERF1, CUL3, CDK2, MYOC, TPI1, TALDO1, AHCYL1, IGBP1, UBE2I, UFC1, PKM, VDAC3, UGDH, UFM1, SSSCA1, PRDX1, UBE2D1, DYNC1LI1, MYC, FN1, SQSTM1, FBXO6, FUS, MAPK8, ACAA2, ACP1, AKR1A1, AKR1B1, AKR1B15, LOC101930400, AKR1C2, ALDH4A1, ALDOA, CALR, COX17, DUT, ENO1, ENO2, ENO3, ESD, FABP5, FABP7, FH, GAPDH, GLRX, GPI, GPX4, HINT1, HSPA4L, HSPE1, IDH1, ITPA, LDHA, LDHAL6B, LDHB, LYPLA2, MIF, NANS, NEDD8, NME1-NME2, NME2, P4HB, PCBP1, PCMT1, PDCD6, PDCD6IP, PGK1, PGM2, PITPNB, PLS3, PMP2, RAB10, RPE, SCYL2, SF1, SOD2, STAT4, STIP1, ABHD14B, AK2, ANXA7, ASS1, C11orf54, CALU, CAPG, CFL1, COTL1, DAZAP1, EZR, FKBP7, FSCN1, GLO1, GLOD4, HSD17B10, HSPA9, HSPB1, LAP3, MSN, PAICS, PIR, PTGES3, RDX, RPIA, RSU1, SLC2A9, SOD1, SPR, SRI, TAGLN2, TAGLN3, C12orf5, VAPA, WDR1, YKT6, VCP, XRCC6, NTRK1, IFI16, PPME1, EXOSC9, PRKCD, MCM2, BCOR, U2AF2, SERPINB5, KHNYN, GREB1, SMG8, DMWD, ATG2B, FIGNL1, POLA2, WDR54, C5orf34, WDR19, MOCOS, POTEF, WDR41, STIL, GOLGA4, MED20, EIF2AK4, TBL1X, CAMK2B, TRIM32, KDM5C, SPC25, MED17, LCMT2, TUBA4A, PLEC, DPP9, EML4, HTT, TRAPPC8, AASDH, TBC1D4, COQ2, DNM1L, SDHA, SOAT1, VDAC1, BRCA1, TES |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SFMBT1_TKT |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SFMBT1_TKT |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | TKT | C0001973 | Alcoholic Intoxication, Chronic | 2 | PSYGENET |
| Tgene | TKT | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| Tgene | TKT | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Tgene | TKT | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| Tgene | TKT | C0043121 | Wernicke Encephalopathy | 1 | CTD_human |
| Tgene | TKT | C0242184 | Hypoxia | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|